Targeting the PI3K-AKT-mTOR signaling network in cancer

par Khan, Khurum H., Yap, Timothy A., Yan, Li, Cunningham, David
Publié 2013

Assessment of fertility control efforts in a selected area of Karachi, Pakistan

par Shirmeen, Amra, Khan, Muhammad FH, Khan, Khizer H, Khan, Khurum H
Publié 2007

Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Mana...

par Khan, Khurum H., Wong, Mabel, Rihawi, Karim, Bodla, Shankar, Morganstein, Daniel, Banerji, Udai, Molife, Lulama R.
Publié dans Oncologist (2016)

Longitudinal liquid biopsy and mathematical modelling of clonal evolution forecast waiting time to treatment failure in the PROSPECT-C phase II colorectal cancer clinical trial

par Khan, Khurum H, Cunningham, David, Werner, Benjamin, Vlachogiannis, Georgios, Spiteri, Inmaculada, Heide, Timon, Mateos, Javier Fernandez, Vatsiou, Alexandra, Lampis, Andrea, Damavandi, Mahnaz Darvish, Lote, Hazel, Huntingford, Ian S., Hedayat, Somaieh, Chau, Ian, Tunariu, Nina, Mentrasti, Giulia, Trevisani, Francesco, Rao, Sheela, Anandappa, Gayathri, Watkins, David, Starling, Naureen, Thomas, Janet, Peckitt, Clare, Khan, Nasir, Rugge, Massimo, Begum, Ruwaida, Hezelova, Blanka, Bryant, Annette, Jones, Thomas, Proszek, Paula, Fassan, Matteo, Hahne, Jens C, Hubank, Michael, Braconi, Chiara, Sottoriva, Andrea, Valeri, Nicola
Publié dans Cancer Discov (2018)